Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
KYNB · against 27 other Healthcare companies of similar size
Ranked #27 of 28 · scores higher than 4% of peers · safety percentile 6
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)4 peers with a safety percentile of 0–9, including KYNB · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | KYNB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 23 reported | Not reported | 0.18× | — | — | 33% |
| BetaLower is better · 27 reported | 1.06 | 0.85 | 42% | 33% | |
| Current ratioHigher is better · 28 reported | 2.69× | 2.58× | 52% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 276M SEK (≈$28M) | 96 | 48 | |
| 2 | 31M USD | 91 | ||
| 3 | 298M SEK (≈$30M) | 83 | 48 | |
| 4 | 22M USD | 81 | 47 | |
| 5 | 2.8B JPY (≈$19M) | 78 | ||
| 23 | 21.3B KRW (≈$15M) | 16 | 28 | |
| 24 | 18M AUD (≈$12M) | 13 | 7 | |
| 25 | 390.5B IDR (≈$24M) | 9 | 8 | |
| 26 | 3.4B JPY (≈$23M) | 7 | 5 | |
| 27 | 17M USD | 6 | 10 | |
| 28 | 17M USD | 3 | 16 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score